
Sanofi has published its Q1 2026 aide-mémoire on its website to assist investors with financial modeling ahead of its quarterly results release on April 23, 2026. The document details non-comparable items, foreign currency impacts, and share count changes. This preparation supports transparency and helps investors anticipate Sanofi's upcoming financial performance. Sanofi is a biopharma company focused on innovative medicines and vaccines, listed on EURONEXT and NASDAQ.